- Home
- PMVP vs OKYO Comparison
PMVP vs OKYO Comparison
Compare PMVP & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMVP | OKYO |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.5M | 85.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PMVP | OKYO |
|---|---|---|
| Price | $1.22 | $1.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 635.4K | 98.0K |
| Earning Date | 03-06-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $1.03 |
| 52 Week High | $1.88 | $3.35 |
Technical Indicators
Market Signals| Indicator | PMVP | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 34.82 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.26 | $1.74 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 2.33 | 16.06 |
Price Performance
Historical ComparisonAbout PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.